← All trials
NCT07291076
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 9, 2026
- Primary completion
- Oct 15, 2029
- Completion date
- Oct 14, 2031
- First posted
- Dec 18, 2025
- Last posted
- Dec 22, 2025
- Enrollment
- 129
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Bristol-Myers SquibbLead sponsor
- BiontechCollaborator
- Bristol-Myers SquibbOfficial
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.